RE:Under $11 againWhy would anyone sell? This is a company that is growing 20 to 30% organically in a defensive sector with massive demographic tailwinds and operating during a pandemic in which the disease attacks those same organs this company was built to treat. If this is not a buy and hold stock in today's unprecedented times, then nothing is.